Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT

Terns Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-91.75M -90.39M -88.85M -88.07M -95.89M -91.06M -90.21M -85.01M -72.07M -68.1M -60.34M -58.77M -53.79M -50.59M -50.16M -45.84M -45.59M -44.7M
Depreciation & Amortization
697K 829K 896K 902K 918K 895K 881K 894K 924K 976K 1.03M 913K 768K 618K 512K 504K 498K 478K
Stock-Based Compensation
13.88M 15.28M 15.63M 15.89M 25.81M 25.63M 25.54M 24.94M 13.54M 11.96M 10.77M 10.63M 9.8M 9.06M 8.15M 6.38M 5.04M 3.32M
Other Working Capital
1.95M 4.2M 5.59M 1.25M -2.14M -5.84M 142K 2.05M 2.95M 4.89M -315K -2.65M -888K -721K -3.15M -5.15M -2.09M -705K
Other Non-Cash Items
66K -2.58M 2.49M 2.15M 1.14M 731K -5.03M -4.1M -2.37M -1.34M 81K 841K 1.4M 1.5M 879K 4.4M 3.57M 1.95M
Deferred Income Tax
-147K -113K -79K 45K 145K 143K 141K 449K 431K 403K 392K 213K 206K 224K 219K -86K 63K 42K
Change in Working Capital
2.85M 5.28M 5.22M -345K -5.8M -6.83M 1.29M 3.54M 7.52M 5.91M -1.04M -2.39M -1.6M -1.61M -1.43M -3.9M -356K 602K
Operating Cash Flow
-74.36M -71.66M -70.02M -74.75M -78.99M -75.81M -67.39M -59.28M -52.02M -50.19M -49.11M -48.57M -43.21M -40.81M -41.83M -38.55M -36.78M -36.84M
Capital Expenditures
n/a -13K -42K -86K -94K -81K -52K -42K -26K -33K -275K -441K -523K -558K -340K -187K -118K -178K
Cash Acquisitions
n/a n/a n/a -47.28K -24.97K -24.97K -24.97K 36.82K 15.76K 31.73K 31.73K 17.21K 15.97K n/a n/a n/a n/a n/a
Purchase of Investments
-144.39M -144.39M -169.94M -55.61M -119.68M -302.51M -275.78M -318.77M -283.95M -139.16M -139.73M -111.44M -91.17M -93.94M -166.3M -146.58M -137.59M -96.79M
Sales Maturities Of Investments
109.25M 125.95M 157.57M 184.87M 194.88M 244.67M 237.85M 219.05M 205.29M 135.36M 117.73M 97.73M 83.23M 81.11M 46.94M 33.44M 19.94M n/a
Other Investing Acitivies
n/a n/a 8.03M 8.07M 8.05M 7.96M -37.94K -99.72K -78.67K -3.8K 9.7M 3.49M 8.01M -12.83M -119.36M -113.14M -117.65M -96.79M
Investing Cash Flow
-35.14M -18.45M -12.41M 129.17M 75.11M -57.92M -37.99M -99.77M -78.69M -3.83M -22.27M -14.15M -8.46M -13.39M -119.7M -113.32M -117.77M -96.97M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.88M
Common Stock Repurchased
252K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.42M 1.75M 1.68M 1.55M 594K 684K 340K 27K -137K -502K -158K -4K 937K -776K -1.97M 66.66M 65.89M 67.48M
Financial Cash Flow
163.99M 164.06M 164M 177.55M 14.28M 14.37M 42.3M 134.66M 195.78M 195.42M 167.5M 61.28M 937K -776K 134.39M 203.02M 202.25M 220.72M
Net Cash Flow
54.47M 73.92M 81.51M 232.24M 10.58M -119.25M -63.31M -25.08M 64.11M 140.47M 95.54M -1.77M -50.78M -54.95M -27.16M 50.95M 47.95M 87.08M
Free Cash Flow
-74.36M -71.67M -70.06M -74.83M -79.09M -75.89M -67.44M -59.33M -52.05M -50.22M -49.38M -49.01M -43.74M -41.37M -42.17M -38.73M -36.89M -37.02M